[Betamethasone phosphate in hematology].
D000741:Anemia, Aplastic / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001623:Betamethasone / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004361:Drug Tolerance; D005260:Female; D006402:Hematologic Diseases / Q000188:drug therapy*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy; D013789:Thalassemia / Q000188:drug therapy
D000970:Antineoplastic Agents; D001623:Betamethasone
Lee phosphate de betaméthasone en hématologie.